CalciMedica, Inc. (CALC)

CIK 0001534133 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 8-K (2026-05-12) · 99.1
FY-2025
Latest FY-2025 8-K (2026-03-03) · 99.1
Q3-2025 8-K (2025-11-12) · 99.1
Q2-2025 8-K (2025-08-12) · 99.1
Q1-2025 8-K (2025-05-14) · 99.1
FY-2024 8-K (2025-03-27) · 99.1
Q3-2024 8-K (2024-11-13) · 99.1  |  8-K (2024-10-30) · 99.1
Q2-2024 8-K (2024-08-12) · 99.1
Q1-2024 8-K (2024-05-13) · 99.1
FY-2023
FY-2023 8-K (2024-03-28) · 99.1  |  8-K (2024-01-22) · 99.1
Q3-2023 8-K (2023-11-09) · 99.1  |  8-K (2023-11-02) · 99.1
Q2-2023 8-K (2023-08-10) · 99.1  |  8-K (2023-05-15) · 99.1
FY-2022

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Condensed Consolidated Statements of Operations and Comprehensive Loss
—
Consolidated Statements of Operations
Condensed Consolidated Statements of Comprehensive (loss) Income
—
Condensed Consolidated Statements of Comprehensive Income (loss) (unaudited)
—
Consolidated Statements of Comprehensive Loss
Condensed Consolidated Statements of Stockholders' Equity (unaudited)
—
Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (deficit)
Consolidated Statements of Stockholders' Equity (deficit)
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (unaudited) (P)
—
Consolidated Statements of Cash Flows
Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (deficit) (P)
Notes
Accrued Expenses
Commitments and Contingencies
Common Stock and Stockholders' Equity
—
Common Stock and Stockholders' Equity (deficit)
—
Common Stock and Stockholders' Equity/ (deficit)
—
Convertible Preferred Stock, Common Stock and Stockholders' Deficit
Convertible Preferred Stock, Common Stock and Stockholders' Equity (deficit)
—
Convertible Promissory Notes and Convertible Promissory Note Warrants
Cybersecurity Risk Management, Strategy and Governance
—
Employee Benefits
Fair Value Measurements
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Merger and Related Transactions
Nature of Business
Net (loss) Income Per Share
—
Net Income (loss) Per Share
—
Net Loss Per Share
Pay Vs Performance Disclosure
Promissory Note
Stock-based Compensation
Subsequent Events
Summary of Significant Accounting Policies